Financials data is unavailable for this security.
View more
Year on year ANI Pharmaceuticals Inc grew revenues 53.87% from 316.39m to 486.82m while net income improved from a loss of 47.90m to a gain of 18.78m.
Gross margin | 59.79% |
---|---|
Net profit margin | -1.28% |
Operating margin | 0.76% |
Return on assets | -0.65% |
---|---|
Return on equity | -2.10% |
Return on investment | -0.77% |
More ▼
Cash flow in USDView more
In 2023, ANI Pharmaceuticals Inc increased its cash reserves by 315.38%, or 167.89m. The company earned 118.96m from its operations for a Cash Flow Margin of 24.44%. In addition the company generated 67.44m cash from financing while 18.51m was spent on investing.
Cash flow per share | 2.66 |
---|---|
Price/Cash flow per share | 22.76 |
Book value per share | 20.44 |
---|---|
Tangible book value per share | -9.46 |
More ▼
Balance sheet in USDView more
Current ratio | 2.74 |
---|---|
Quick ratio | 1.97 |
Total debt/total equity | 1.45 |
---|---|
Total debt/total capital | 0.5921 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | -8.16 |
---|---|
EPS (TTM) vs TTM 1 year ago | -189.81 |